Skip to main content

Clinical guidance for the management of lobular carcinoma in situ

This document aims to provide health professionals within a multidisciplinary team with information to assist in the management of women with lobular carcinoma in situ.

Background

In the absence of a comprehensive evidence base, the guidance in this document has been developed through a consensus process by an expert multidisciplinary Working Group convened by Cancer Australia. 

External consultation was sought and received from peak organisations, including Breast Cancer Network Australia, BreastScreen Australia, Breast Surgeons of Australia and New Zealand, The Cancer Nurses Society of Australia, The Medical Oncology Group of Australia, The Royal Australian and New Zealand College of Radiologists and The Royal College of Pathologists of Australasia.

 

Download the clinical practice guideline

Download PDF

Endorsed by:

Endorsement logos for clinical guidance for the management of lobular carcinoma in situ
Last updated 13 November 2024
Cancer Australia

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care.

If you would like an interpreter to help you understand any information on this website, please call TIS National on 131 450 and ask them to call Cancer Australia on 02 9357 9400. Our business hours are 9am to 5pm, Monday to Friday.

© 2025 Cancer Australia. All rights reserved.